Incremental improvements to ultra-high performance liquid chromatography (UHPLC) have failed to deliver the tangible advances that researchers really want. Sometimes, a full overhaul by re-engineering from the bottom-up is the only way to innovate and move the field forward.

Does the fabrication of nanoparticles and nanocapules sound complex? Don’t worry – layer by layer technology allows for simple fabrication of complicated stuff.

A personal experience led us to examine how adverse drug events data can be used to benefit the industry.

The serialization deadlines are coming. It may seem an age away, but preparing for serialization is not as straightforward as you may think. Do you really want to get left behind?

The final deadline for the European Union’s REACH regulation is approaching – and the home stretch will be the most challenging, especially for pharma companies that have failed to recognize their role.

Are current dosage forms really as easy and convenient for patients as pharma manufacturers say they are?

Nanoparticles help to deliver a three-in-one attack on metastatic melanoma cells

From anti-cancer viruses to H3 blocking narcolepsy drugs – we present a year in European drug approvals

We live in exciting times for the biopharma industry.

A clinical trial of an FAAH inhibitor in France goes terribly wrong, but whether the compound or manufacturing are to blame remains to be seen